Bruker (BRKRP) Other financing activities (2010 - 2026)

Bruker has reported Other financing activities for 12 years, with the latest figure at -$5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 614.29% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2026 stood at -$12.6 million (up 37.0% YoY), and the FY2025 full-year result was -$8.3 million, up 66.67% from the prior year.
• Other financing activities for Q1 2026 stood at -$5.0 million, up from -$9.4 million in the prior quarter.
• The five-year high for Other financing activities was $6.5 million in Q3 2025, with the low at -$17.0 million in Q4 2024.
• Historically, Other financing activities has averaged -$3.6 million across 5 years, with a median of -$3.2 million in 2022.
• Annual changes were most pronounced in 2025 — Other financing activities jumped 822.22% — and 2026, when it sank 614.29%.
• Bruker's Other financing activities stood at -$1.2 million in 2022, then plunged by 166.67% to -$3.2 million in 2023, then slumped by 431.25% to -$17.0 million in 2024, then soared by 44.71% to -$9.4 million in 2025, then soared by 46.81% to -$5.0 million in 2026.
• The last three Other financing activities figures came in at -$5.0 million (Q1 2026), -$9.4 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.